LEADER 01227nam0-22003611i-450-
001 990001362610403321
005 20110809161704.0
010   $a0-521-55736-4
035   $a000136261
035   $aFED01000136261
035   $a(Aleph)000136261FED01
035   $a000136261
100   $a20001205d1996----km-y0itay50------ba
101 0 $aeng
200 1 $aComputability, enumerability, unsolvability$edirections in recursion theory$fedited by S. B. Cooper, T. A. Slaman, S. S. Wainer
210   $aCambridge$cCambridge University Press$dc1996
215   $avii, 347 p.$d23 cm
225 1 $aLondon Mathematical Society lecture note series$v224
300   $aNella prefazione: This volume is a collection of refereed research articles commemorating The Leeds Recursion Theory Year 1993-94
610 0 $aTeoria della ricorsivita$aCongressi
676   $a511.35
702  1$aCooper,$bS. Barry
702  1$aSlaman,$bT. A.
702  1$aWainer,$bStanley S.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990001362610403321
952   $aC-9-(224$b14659$fMA1
959   $aMA1
962   $a03-06
962   $a03DXX
996   $aComputability, enumerability, unsolvability$9375477
997   $aUNINA

LEADER 01449nam0-22004091i-450-
001 990005550850203316
005 20080702120000.0
035   $a000555085
035   $aUSA01000555085
035   $a(ALEPH)000555085USA01
035   $a000555085
100   $a20080702d2007-------|0itac50------ba
101   $aita
102   $aIT
105   $a|||| |||||
200 1 $aSettore farmaceutico e sistema Paese: contributi ed esigenze per uno sviluppo sostenibile$eGlaxoSmithKline: il valore di un investimento duraturo$fNomisma
210   $aBologna$cIl Mulino$dc2007
215   $a147 p.$cill.$d22 cm.
225  2$aPercorsi. - Bologna
410  1$12001$aPercorsi. - Bologna
606   $aGlaxoSmithKline$xItalia$xStoria$2FI
606   $aIndustria farmaceutica$xItalia$2FI
620   $dBologna
676   $a338.4761510945$cMerci e servizi. Farmaci (farmacologia, chimica farmaceutica). Italia$v21
710 02$aNomisma$0293903
801   $aIT$bSOL$c20120104
912   $a990005550850203316
950   $aDIP.TO SCIENZE ECONOMICHE - (SA)$dDS 300 338.476151 NOM$e14112 DISES
951   $a300 338.476151 NOM$b14112 DISES
959   $aBK
969   $aDISES
979   $c20121027$lUSA01$h1533
979   $c20121027$lUSA01$h1613
979   $aPATRY$b90$c20130312$lUSA01$h1700
996   $aSettore farmaceutico e sistema Paese: contributi ed esigenze per uno sviluppo sostenibile$91131398
997   $aUNISA
NUM   $aUSA17755